YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Investigating the Impact of Self-monitoring Feedback for Health Behaviors

Not Applicable

Completed

Conditions: Obesity

Interventions: Device: weight scale
Device: step counter
Device: step counter with screen covered

First Posted Date: 2019-05-07

Last Posted Date: 2021-07-15

Lead Sponsor: Yale University

Target Recruit Count: 44

Registration Number: NCT03940599

Locations: 🇼🇸
Olaga Research Laboratory - Ministry of Health, Apia, Samoa

Brief ROC Training Effects on Alcohol Drinking

Not Applicable

Terminated

Conditions: Alcohol Drinking in College
Drinking Behavior
Drunkenness
Young Adult
Heavy Drinking
Drinking Excessive
Heavy Drinker
Alcohol Drinking
Drink Too Much
Binge Drinking

Interventions: Behavioral: Control (NO REGULATION)
Behavioral: Regulation of craving

First Posted Date: 2019-04-26

Last Posted Date: 2024-02-28

Lead Sponsor: Yale University

Target Recruit Count: 57

Registration Number: NCT03928626

Locations: 🇺🇸
Clinical & Affective Neuroscience Lab, New Haven, Connecticut, United States

Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Maintenance Treatment

Phase 3

Completed

Conditions: Binge-Eating Disorder
Obesity

Interventions: Drug: Placebo
Drug: Lisdexamfetamine Dimesylate

First Posted Date: 2019-04-24

Last Posted Date: 2025-03-07

Lead Sponsor: Yale University

Target Recruit Count: 61

Registration Number: NCT03926052

Locations: 🇺🇸
Yale Department of Psychiatry, New Haven, Connecticut, United States

Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Acute Treatment

Phase 3

Completed

Conditions: Obesity
Binge-Eating Disorder

Interventions: Other: Combination LDX and Cognitive-Behavioral Therapy
Behavioral: Cognitive-Behavioral Therapy
Drug: Lisdexamfetamine Dimesylate

First Posted Date: 2019-04-23

Last Posted Date: 2024-10-17

Lead Sponsor: Yale University

Target Recruit Count: 141

Registration Number: NCT03924193

Locations: 🇺🇸
Yale Department of Psychiatry, New Haven, Connecticut, United States

Application of Electrical Impedance Myography (EIM) as a Potential Biomarker of Idiopathic Inflammatory Myopathies

Not Applicable

Completed

Conditions: Idiopathic Inflammatory Myopathies

Interventions: Device: electrical impedance myography
Other: healthy control group

First Posted Date: 2019-04-17

Last Posted Date: 2021-09-05

Lead Sponsor: Yale University

Target Recruit Count: 5

Registration Number: NCT03918356

Locations: 🇺🇸
Bhaskar Roy, New Haven, Connecticut, United States

Relief of Symptoms of Post-traumatic Stress for Victims of Gun Violence

Not Applicable

Completed

Conditions: Stress, Psychological
PTSD
Gunshot Wound

Interventions: Behavioral: standard of care
Behavioral: Screening Tool for Relief of Trauma (START)

First Posted Date: 2019-04-16

Last Posted Date: 2022-04-14

Lead Sponsor: Yale University

Target Recruit Count: 14

Registration Number: NCT03916614

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Open-label Trial of Tofacitinib in Cutaneous Sarcoidosis and Granuloma Annulare

Phase 1

Completed

Conditions: Cutaneous Sarcoidosis
Granuloma Annulare

Interventions: Drug: Tofacitinib 5 mg twice daily

First Posted Date: 2019-04-10

Last Posted Date: 2021-07-14

Lead Sponsor: Yale University

Target Recruit Count: 15

Registration Number: NCT03910543

Locations: 🇺🇸
Yale Center for Clinical Investigation, New Haven, Connecticut, United States

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

Phase 3

Recruiting

Conditions: Atrial Fibrillation
Intracerebral Hemorrhage

Interventions: Drug: Apixaban
Drug: Aspirin

First Posted Date: 2019-04-08

Last Posted Date: 2025-03-25

Lead Sponsor: Yale University

Target Recruit Count: 700

Registration Number: NCT03907046

Locations: 🇺🇸
University of South Alabama University Hospital, Mobile, Alabama, United States
🇺🇸
Chandler Regional Medical Center, Chandler, Arizona, United States
🇺🇸
St. Mary's Medical Center, Grand Junction, Colorado, United States

and more 166 locations

Imaging mGluR5 and Synaptic Density in Psychiatric Disorders

Active, not recruiting

Conditions: Major Depressive Disorder
Healthy
Bipolar Disorder

Interventions: Radiation: [18F]FPEB
Radiation: [11C]APP311

First Posted Date: 2019-04-01

Last Posted Date: 2025-01-03

Lead Sponsor: Yale University

Target Recruit Count: 90

Registration Number: NCT03898297

Locations: 🇺🇸
Yale University PET Center, New Haven, Connecticut, United States

Ketamine for Severe Adolescent Depression: Intermediate-term Safety and Efficacy

Phase 2

Terminated

Conditions: Major Depressive Disorder

Interventions: Drug: Midazolam infusion
Drug: Ketamine infusion

First Posted Date: 2019-03-26

Last Posted Date: 2023-04-24

Lead Sponsor: Yale University

Target Recruit Count: 3

Registration Number: NCT03889756

Locations: 🇺🇸
Yale Child Study Center, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy